A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)
Clinical trial NCT06561360 · RECRUITING
Trial details
- NCT number
- NCT06561360
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-09
- Primary completion
- 2027-09-09
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.